Adding L-carnitine to antagonist ovarian stimulation doesn't improve the outcomes of IVF/ ICSI cycle in patients with polycystic ovarian syndrome: a double-blind randomized clinical trial.
- 2024-01-09
- RCT · n = 110
- Journal of ovarian research 17(1)
- Maryam Hafezi
- Arezoo Arabipoor
- Firouzeh Ghaffari
- Samira Vesali
- Maryam Zareei
- Zahra Hajinaghibali Hessari
- PubMed: 38191449
- DOI: 10.1186/s13048-023-01319-7
- High evidence
- Large Human Trial
- Clinical
There is no statistically significant difference in terms of the oocyte recovery ratio and oocyte maturity rate, and the number and quality of embryos, as well as the rates of the fertilization, chemical and clinical pregnancy between groups.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 3000 mg/day (3 tablets daily of 1000 mg L-carnitine)